Your session is about to expire
What is A-Methapred
Methylprednisolone hemisuccinateThe Generic name of this drug
Treatment SummaryMethylprednisolone sodium succinate is an injectable form of the steroid methylprednisolone. It is used to treat cardiac emergencies, allergic reactions, and oxygen-related issues.
Solu-medrolis the brand name
A-Methapred Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Solu-medrol
Methylprednisolone hemisuccinate
1959
89
Approved as Treatment by the FDA
Methylprednisolone hemisuccinate, also known as Solu-medrol, is approved by the FDA for 5 uses including Tuberculosis, Pulmonary and Tuberculosis, Pulmonary .Tuberculosis, Pulmonary
Used to treat fulminating Pulmonary Tuberculosis in combination with null
Tuberculosis, Pulmonary
Used to treat disseminated Pulmonary Tuberculosis (TB) in combination with null
Tuberculous Meningitis
Used to treat Tuberculous Meningitis in combination with null
Tuberculosis, Meningeal
Used to treat Tuberculous Meningitis in combination with null
Subarachnoid Block
Used to treat Subarachnoid Block in combination with null
Effectiveness
How A-Methapred Affects PatientsMethylprednisolone sodium succinate is a form of methylprednisolone that works in the same way to reduce inflammation. When given in the same amount, it has the same effects as methylprednisolone.
When to interrupt dosage
The suggested dosage of A-Methapred is contingent upon the recognized condition, including Idiopathic Thrombocytopenic Purpura, Multiple Sclerosis and Pure Red Cell Aplasia. The measure of dosage is contingent upon the administration approach (e.g. Injection, powder, lyophilized, for solution - Intramuscular; Intravenous or Kit; Powder, for solution) presented in the table beneath.Condition
Dosage
Administration
Mycosis Fungoides
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Polymyositis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Addison Disease
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Eosinophilic Pneumonia
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Dermatitis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Multiple Sclerosis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Trichinosis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Thrombocytopenia
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Sarcoidosis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Acute Coryza
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Anemia, Hemolytic
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Craniotomy
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Thyroiditis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
exfoliative erythroderma
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
induction of Diuresis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Diuresis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Arthritis, Gouty
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Giant Cell Arteritis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Brain
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Dermatomyositis
, 40.0 mg/mL, 125.0 mg/mL, 1000.0 mg, 40.0 mg, 100.0 mg/mL, 125.0 mg, 500.0 mg/mL, 1000.0 mg/mL, 500.0 mg, 2000.0 mg, 200.0 mg/mL, 5000.0 mg
, Intramuscular; Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intramuscular; Intravenous, Intravenous, Powder, for solution, Powder, for solution - Intravenous, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Injection, powder, for solution - Intramuscular; Intravenous, Intramuscular; Intravenous; Rectal, Powder, for solution - Intramuscular; Intravenous; Rectal, Intracavernous; Intramuscular, Injection, powder, for solution - Intracavernous; Intramuscular, Injection - Intramuscular; Intravenous, Injection, Kit; Powder, Kit; Powder, for solution, Kit; Powder, for solution - Intramuscular; Intravenous, Kit; Powder - Intramuscular; Intravenous, Powder, for solution - Intramuscular; Intravenous
Warnings
A-Methapred has three contraindications, and it should not be taken together with any of the disorders shown in the following table.A-Methapred ContraindicationsCondition
Risk Level
Notes
intrathecal administration
Do Not Combine
Mycoses
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Methylprednisolone Hemisuccinate may interact with Pulse Frequency
Common A-Methapred Drug Interactions
Drug Name
Risk Level
Description
Aldesleukin
Major
The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Methylprednisolone hemisuccinate.
Corticorelin ovine triflutate
Major
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Methylprednisolone hemisuccinate.
Macimorelin
Major
The therapeutic efficacy of Macimorelin can be decreased when used in combination with Methylprednisolone hemisuccinate.
1,10-Phenanthroline
Minor
The therapeutic efficacy of 1,10-Phenanthroline can be decreased when used in combination with Methylprednisolone hemisuccinate.
Aceclofenac
Minor
The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone hemisuccinate is combined with Aceclofenac.
A-Methapred Novel Uses: Which Conditions Have a Clinical Trial Featuring A-Methapred?
207 active clinical trials are currently being conducted to assess the potential of A-Methapred in providing Palliative Care, Ulcerative Colitis and Eosinophilic Pneumonia relief.Condition
Clinical Trials
Trial Phases
Metastatic Brain Tumors
60 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 3, Phase 4
Psoriatic Arthritis
25 Actively Recruiting
Phase 3, Not Applicable, Phase 1, Phase 4, Phase 2
Ulcerative Colitis
13 Actively Recruiting
Phase 3, Not Applicable, Phase 2, Phase 1
Thrombocytopenia
0 Actively Recruiting
Palliative Treatment
1 Actively Recruiting
Not Applicable
Berylliosis
0 Actively Recruiting
Adrenal Insufficiency
0 Actively Recruiting
Diuresis
0 Actively Recruiting
Anemia, Hemolytic
0 Actively Recruiting
Brain
0 Actively Recruiting
Brain
7 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Early Phase 1
Lupus Erythematosus
3 Actively Recruiting
Phase 4, Phase 1
Crohn Disease
0 Actively Recruiting
Subarachnoid Block
0 Actively Recruiting
Stevens-Johnson Syndrome
2 Actively Recruiting
Phase 3, Phase 1
exfoliative erythroderma
0 Actively Recruiting
Arthritis, Gouty
0 Actively Recruiting
Addison Disease
0 Actively Recruiting
Multiple Sclerosis
0 Actively Recruiting
Craniotomy
0 Actively Recruiting
Patient Q&A Section about a-methapred
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What does methylprednisolone?
"This medicine is only available with a prescription from a doctor. It works by helping to reduce inflammation, swelling, itchiness, and allergic reactions."
Answered by AI
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.